CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-03 | El-Hibri Fuad Director | Other acquisition | +3,018,644 | 3,018,644 | ||
| 2021-12-03 | El-Hibri Fuad Director | Other acquisition | +274,930 | 274,930 | ||
| 2021-12-03 | El-Hibri Fuad Director | Other acquisition | +206,434 | 206,434 | ||
| 2021-02-24 | El-Hibri Fuad Chairman | Grant or award · Employee Stock Options (Right to Buy) | +27,808 | 27,808 | ||
| 2021-02-24 | El-Hibri Fuad Chairman | Grant or award · Restricted Stock Unit | +13,906 | 13,906 | ||
| 2020-11-10 | El-Hibri Fuad Chairman | Exercise or conversion | +19,391 | $26.45 | $513K | 1,143,379 |
| 2020-11-10 | El-Hibri Fuad Chairman | Sale | −19,391 | $88.21 | $1.7M | 1,123,988 |
| 2020-11-10 | El-Hibri Fuad Chairman | Exercise or conversion · Stock Options (Right to Buy) | −19,391 | 0 | ||
| 2020-11-09 | El-Hibri Fuad Chairman | Exercise or conversion | +20,000 | $26.45 | $529K | 1,143,988 |
| 2020-11-09 | El-Hibri Fuad Chairman | Sale | −20,000 | $95.26 | $1.9M | 1,123,988 |
| 2020-11-09 | El-Hibri Fuad Chairman | Exercise or conversion · Stock Options (Right to Buy) | −20,000 | 19,391 | ||
| 2020-11-03 | El-Hibri Fuad Chairman | Exercise or conversion | +20,000 | $26.45 | $529K | 1,143,988 |
| 2020-11-03 | El-Hibri Fuad Chairman | Sale | −20,000 | $90.74 | $1.8M | 1,123,988 |
| 2020-11-03 | El-Hibri Fuad Chairman | Exercise or conversion · Stock Options (Right to Buy) | −20,000 | 39,391 | ||
| 2020-11-02 | El-Hibri Fuad Chairman | Exercise or conversion | +20,000 | $26.45 | $529K | 1,143,988 |
| 2020-11-02 | El-Hibri Fuad Chairman | Sale | −20,000 | $90.44 | $1.8M | 1,123,988 |
| 2020-11-02 | El-Hibri Fuad Chairman | Exercise or conversion · Stock Options (Right to Buy) | −20,000 | 59,391 | ||
| 2020-09-24 | El-Hibri Fuad Chairman | Sale | −12,535 | $98.85 | $1.2M | 1,123,988 |
| 2020-09-23 | El-Hibri Fuad Chairman | Sale | −13,000 | $100.58 | $1.3M | 1,136,523 |
| 2020-09-17 | El-Hibri Fuad Chairman | Sale | −20,000 | $100.68 | $2.0M | 1,149,523 |
Page 1 of 8 · 142 trades